Host: | Mouse |
Applications: | IHC-P |
Reactivity: | Human |
Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description : | Mouse monoclonal antibody anti-Herpesvirus 8 is suitable for use in Immunohistochemistry research applications. |
Clonality : | Monoclonal |
Clone ID : | 13B10 |
Conjugation: | Unconjugated |
Isotype: | IgG1 |
Formulation: | Tissue culture supernatant with sodium azide |
Concentration: | >=35 mg/L |
Dilution Range: | IHC-P 1:50 |
Storage Instruction: | Store at 2-8°C upon receipt. |
Immunogen: | Prokaryotic recombinant protein corresponding to a portion of the C-terminus of the latent nuclear antigen-1 molecule of HHV8. |
Background | Human herpesvirus type 8 (HHV8) , is the proposed etiological agent of Kaposi s sarcoma (KS). It is reported that HHV8 has been demonstrated in KS tissues by immunohistochemistry, in situ PCR and also in situ hybridization. HHV8 encodes a latent nuclear antigen (LNA) which is the product of the viral gene ORF73. LNA is capable of forming a complex with retinoblastoma susceptibility gene product which may be related to its oncogenic activity. HHV8 has been reported to be expressed in multicentric Castleman s disease (MCD) and in angioimmunoblastic lymphadenopathies. The localization of HHV8 in subcapsular spindle cell proliferations, which is where early intranodal KS begins, and endothelial cells in Castleman s disease may explain the link between intranodal KS and MCD. In MCD, HHV8 is reported to be expressed in mantle zone large immunoblastic B cells. |
Information sourced from Uniprot.org